Biotech Intelligence & Pharmaceutical Innovation

2026-07-10

Landmark clinical evidence demonstrates that BNCT can dramatically improve progression-free survival for recurrent high-grade meningioma. Combined with China's rapid advances in accelerator-based BNCT systems, boron drugs, and national policy support, BNCT is emerging as one of the most promising precision radiotherapy technologies.

2026-06-26

A comprehensive review of perioperative antibiotic prophylaxis, including surgical indications, antibiotic selection, administration timing, duration control, common misconceptions, and future trends in antimicrobial stewardship.

2026-06-22

Discover the five leading Chinese AI drug discovery companies transforming pharmaceutical innovation through artificial intelligence, generative AI, robotics, and computational biology. From XtalPi and Insilico Medicine to BioMap and Galixir, China's AI-powered biotech sector is rapidly becoming a major force in global drug development.

2026-06-18

PROTAC technology is transforming drug discovery by shifting the focus from inhibiting disease proteins to eliminating them entirely. Learn how targeted protein degradation could reshape the future of precision medicine.

2026-05-29

As GLP-1 demand explodes globally, China is rapidly becoming one of the world’s most important peptide manufacturing hubs.

2026-05-28

As global demand for GLP-1 therapies surges, the peptide API industry is rapidly transitioning from small-scale synthesis to industrialized manufacturing.

2026-05-21

China’s biopharmaceutical industry is entering a new phase driven by policy reform, innovation, and global expansion.

2026-05-20

China’s innovative drugs sector is accelerating global collaboration through policy support, clinical progress, and expanding outbound licensing activity.